BACKGROUND: People with HIV (PWH) and community members have advocated for the development of a home-based viral load test device that could make analytical treatment interruptions (ATIs) less burdensome. OBJECTIVE: We assessed community acceptability of a novel home-based viral load test device. METHODS: In 2021, we conducted 15 interviews and 3 virtual focus groups with PWH involved in HIV cure research. We used conventional thematic analysis to analyze the data. RESULTS: PWH viewed the home-based viral load test device as a critical adjunct in ongoing HIV cure trials with ATIs. The ability to test for viral load at home on demand would alleviate anxiety around being off ART. Participants drew parallels with glucometers used for diabetes. A preference was expressed for the home-based test to clearly indicate whether one was detectable or undetectable for HIV to mitigate risk of HIV transmission to partners. Perceived advantages of the device included convenience, sense of control, and no puncturing of veins. Perceived concerns were possible physical marks, user errors and navigating the logistics of mailing samples to a laboratory and receiving test results. Participants expressed mixed effects on stigma, such as helping normalize HIV, but increased potential for inadvertent disclosure of HIV status or ATI participation. Increasing pluri-potency of the device beyond viral load testing (e.g., CD4+ count test) would increase its utility. Participants suggested pairing the device with telemedicine and mobile health technologies. CONCLUSIONS: If proven effective, the home-based viral load test device will become a critical adjunct in HIV cure research and HIV care.
BACKGROUND: People with HIV (PWH) and community members have advocated for the development of a home-based viral load test device that could make analytical treatment interruptions (ATIs) less burdensome. OBJECTIVE: We assessed community acceptability of a novel home-based viral load test device. METHODS: In 2021, we conducted 15 interviews and 3 virtual focus groups with PWH involved in HIV cure research. We used conventional thematic analysis to analyze the data. RESULTS: PWH viewed the home-based viral load test device as a critical adjunct in ongoing HIV cure trials with ATIs. The ability to test for viral load at home on demand would alleviate anxiety around being off ART. Participants drew parallels with glucometers used for diabetes. A preference was expressed for the home-based test to clearly indicate whether one was detectable or undetectable for HIV to mitigate risk of HIV transmission to partners. Perceived advantages of the device included convenience, sense of control, and no puncturing of veins. Perceived concerns were possible physical marks, user errors and navigating the logistics of mailing samples to a laboratory and receiving test results. Participants expressed mixed effects on stigma, such as helping normalize HIV, but increased potential for inadvertent disclosure of HIV status or ATI participation. Increasing pluri-potency of the device beyond viral load testing (e.g., CD4+ count test) would increase its utility. Participants suggested pairing the device with telemedicine and mobile health technologies. CONCLUSIONS: If proven effective, the home-based viral load test device will become a critical adjunct in HIV cure research and HIV care.
Entities:
Keywords:
HIV cure research; Home-based viral load; acceptability; analytical treatment interruptions; people with HIV
Authors: Karine Dubé; David Evans; Lynda Dee; Laurie Sylla; Jeff Taylor; Asheley Skinner; Bryan J Weiner; Sandra B Greene; Stuart Rennie; Joseph D Tucker Journal: AIDS Res Hum Retroviruses Date: 2017-07-10 Impact factor: 2.205
Authors: M Armstrong-Hough; J Ggita; P Turimumahoro; A J Meyer; E Ochom; D Dowdy; A Cattamanchi; A Katamba; J L Davis Journal: Int J Tuberc Lung Dis Date: 2018-10-01 Impact factor: 2.373
Authors: J A Kahn; D I Bernstein; S L Rosenthal; B Huang; L M Kollar; J L Colyer; A M Tissot; P A Hillard; D Witte; P Groen; G B Slap Journal: Sex Transm Infect Date: 2005-10 Impact factor: 3.519
Authors: Karine Dubé; John Kanazawa; Lynda Dee; Jeff Taylor; Danielle M Campbell; Brandon Brown; Mallory O Johnson; Parya Saberi; John A Sauceda; Jeremy Sugarman; Michael J Peluso Journal: HIV Res Clin Pract Date: 2021-03-24
Authors: Aaron J Siegler; Kenneth H Mayer; Albert Y Liu; Rupa R Patel; Lauren M Ahlschlager; Colleen S Kraft; Rossi Fish; Sarah E Wiatrek; Patrick S Sullivan Journal: Clin Infect Dis Date: 2019-01-18 Impact factor: 9.079
Authors: Michael J Peluso; Lynda Dee; Danielle Campbell; Jeff Taylor; Rebecca Hoh; Rachel L Rutishauser; John Sauceda; Steven G Deeks; Karine Dubé Journal: J Virus Erad Date: 2020-02-20
Authors: Karine Dubé; Harsh Agarwal; William B Carter; Lynda Dee; Jeff Taylor; Christopher Roebuck; Beth Peterson; Hursch Patel; Samuel Ndukwe; Kenneth M Lynn; Linden Lalley-Chareczko; Emily Hiserodt; Sukyung Kim; Daniel Rosenbloom; Brad R Evans; Melanie Anderson; Daria J Hazuda; Kevin Bateman; Bonnie J Howell; Livio Azzoni; Karam Mounzer; Pablo Tebas; Luis J Montaner Journal: HIV Res Clin Pract Date: 2022-08-02